Therapeutic Cold Lasers for Professionals
IMIHT is the developer and manufacturer of the Laser Therapy SystemIMI Healing Technologies’ prime mission is to bring the recognition and use by medical communities in North America and around the Globe of its LEP2000™ Photonic and Laser Therapy System, and to offer high-efficacy therapeutic devices based on scientifically and clinically proven healing properties of multi-modality photonic and laser therapy approaches.
IMIHT is the world leader in therapeutic efficacy and versatility of the multi-modality LEP2000™ Photonic and Laser Therapy System and its modules
IMI Healing Technologies is the developer and manufacturer of the superior efficacy LEP2000™ Photonic and Laser Therapy System and its modules used for pain treatment, nerve regeneration, wound and tissue healing. IMI Healing Technologies (IMIHT) carries on research and development, and attends to the manufacture, distribution and servicing of LEP2000™ therapeutic lasers and cluster modules of light emitting diodes that feature high efficacy for a broad variety of medical applications.
EDUCATION & TRAINING
IMI Healing Technologies (IMIHT) is the operating name for a Canadian corporation - International Medical Instruments Inc. (IMI Inc.). IMI Inc. was founded in 1984 by a Canadian scientist Dr. Norman Salansky, PhD, and operated initially under the name International Medical Machines Inc. IMIHT is the world leader in therapeutic efficacy and versatility of the multi-modality LEP2000™ Photonic and Laser Therapy System and its modules (see clinical evidence and laser therapy advancements).
The development of the above technology is predicated by the interdisciplinary nature of photon and tissue interaction phenomena. It is therefore necessary to combine the expertise of proficient medical authorities in the field of pain management, physical medicine and rehabilitation, sports medicine, rheumatology, neurology, immunology, etc., and specialists in photon sources (lasers, LEDs, SLDs and other light sources) to ensure control of the parameters governing software development in order to obtain required 3D photon distributions in the tissue that will activate specific healing mechanisms.
Based on the above considerations, the corporate structure includes in-house expertise of the core group together with external medical expertise (see the diagram below).
Synergy of Interdisciplinary Interactive Approach
1+1 = ∞∞ - infinite gain in development of a scientifically sound and clinically proven technology
The core of the corporation consists of scientists and engineers in the field of optical sources (lasers, LEDs, clusters, etc.) and software and hardware specialists capable of providing control for the sources of output parameters for the optimization of different therapeutic applications. They also have expertise in Monte-Carlo and Neural Network software to calculate 3D distribution of photons in the tissue, as well as expertise in hardware design and construction of biomedical devices and regulatory issues.
A medical advisory committee was set up with a mandate among others to consult the core group in different areas of medicine such as pain management, sports medicine, rheumatology, neurology, physical medicine and rehabilitation, immunology, and other specialties.
As a result of an interactive collaborative effort with these specialists the core group developed the main concepts for the design of an effective LEP2000™ Photonic and Laser Therapy System family of therapeutic devices.
The basic concepts are:
Over the last 25 Years, the IMIHT scientific team, in close collaboration with university scientists and medical doctors, has conducted research on key aspects of the healing mechanisms that could be inducedin biotissue by monochromatic light. Special emphasis of this research was made on so-called dosimetry of photon-biotissue interactions - an in-depth investigation of optical parameters that are required to induce particular healing mechanisms and therapeutic effects.
The main goal of IMIHT research was to perfect the therapeutic efficacy and versatility of its medical devices. Leading IMIHT scientists Dr. Norman Salansky, PhD, and Dr. Natasha Salansky PhD, DAc, developed clinical protocols for effective pain treatment, nerve regeneration, and tissue healing using the LEP2000™ system. This research was supported by Canadian Government grants with the first grant received from the National Research Council of Canada in 1985 (see grants).
For over two decades, high therapeutic efficacy of LEP2000™ Photonic and Laser Therapy System has been identified in numerous clinical studies including controlled and double blind clinical trials (see clinical evidence).
The company obtained Health Canada and FDA approvals and its intellectual property is covered by comprehensive patents.